Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

ACell wins additional clearances from US FDA for Gentrix Surgical Matrix hernia portfolio.

Document Cited in Related
Vincent

Global Banking News-April 4, 2019-ACell wins additional clearances from US FDA for Gentrix Surgical Matrix hernia portfolio

(C)2019 ENPublishing - http://www.enpublishing.co.uk

Medicine company ACell Inc revealed on Wednesday the receipt of new 510(k) clearance from the US Food and Drug Administration (FDA) for several devices for complex hernia repair under its Gentrix Surgical Matrix suite of products.

This clearance expands the specific indications to add new claims to the product labelling in Gentrix Surgical Matrix, Gentrix Surgical Matrix Thin and Gentrix Surgical Matrix Plus. The devices were shown to minimise unwanted attachment to surrounding visceral tissue and ACell gained specific indication for use of these three Gentrix devices in laparoscopic applications. It also obtained clearance for a new hernia device configuration specifically indicated for reinforcement of hiatal hernia repairs.

On 3-6 April 2018, the pre-clinical data used to support the...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT